Land: Bretland
Tungumál: enska
Heimild: MHRA (Medicines & Healthcare Products Regulatory Agency)
Amitriptyline hydrochloride
Wockhardt UK Ltd
N06AA09
Amitriptyline hydrochloride
2mg/1ml
Oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04030100; GTIN: 5012727906775
PACKAGE LEAFLET: INFORMATION FOR THE USER Amitriptyline Hydrochloride 10mg/5ml Oral Solution READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TO TAKE THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, please ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Amitriptyline Oral Solution is and what it is used for 2. What you need to know before you take Amitriptyline Oral Solution 3. How to take Amitriptyline Oral Solution 4. Possible side effects 5. How to store Amitriptyline Oral Solution 6. Contents of the pack and other information 1. What Amitriptyline Oral Solution is and what it is used for The name of your medicine is Amitriptyline Oral Solution. Amitriptyline belongs to a group of medicines known as tricyclic antidepressants. Everybody has substances called serotonin and noradrenaline in their brains. It is thought that people with depression (and some other conditions) have less of these substances compared to those without depression (or other conditions). Amitriptyline works by increasing the amounts of these substances in the brain. Amitriptyline also affects the muscles in the bladder and reduces the need to pass urine. Amitriptyline Oral Solution is used in the treatment of: • depression (especially when associated with sleep disturbance) • night-time bed-wetting in children aged six years and above. 2. What you need to know before you take Amitriptyline Oral Solution DO NOT TAKE AMITRIPTYLINE ORAL SOLUTION IF YOU: • are allergic to amitriptyline or to any of the other ingredients of this medicine (listed in section 6) • are taking drugs called Monoamine Oxidase Inhibitors (MAOIs) Lestu allt skjalið
OBJECT 1 AMITRIPTYLINE HYDROCHLORIDE 10MG/5ML ORAL SOLUTION Summary of Product Characteristics Updated 06-Dec-2016 | Wockhardt UK Ltd 1. Name of the medicinal product Amitriptyline Hydrochloride 10mg/5ml Oral Solution 2. Qualitative and quantitative composition Each 5ml of solution contains 10mg amitriptyline hydrochloride. Excipients with known effect Each 5ml of solution contains: 1mg propyl hydroxybenzoate (E216) 6mg methyl hydroxybenzoate (E218) 3.35g liquid maltitol Approximately 10.5mg ethanol For full list of excipients, see section 6.1. 3. Pharmaceutical form Oral solution. A clear colourless to pale yellow solution with an orange/tangerine odour. 4. Clinical particulars 4.1 Therapeutic indications Amitriptyline is indicated for the treatment of: -Symptoms of depression (especially where sedation is required). - Nocturnal enuresis in children aged six years and above when organic pathology has been excluded and no response has been achieved to all other non-drug and drug treatments (used only as third line therapy). Amitriptyline should only be prescribed by a healthcare professional with expertise in the management of persistent enuresis. 4.2 Posology and method of administration Posology Therapy should be started with a low dosage and increased gradually, according to the clinical response and any evidence of intolerance. Adults - initial dosage: Usually 75mg a day in divided doses (or a single dose at night). If necessary, this may be increased to a total of 150mg a day, the additional doses being given in the late afternoon and/or at bedtime. The sedative effect is usually rapidly apparent. The antidepressant activity may be seen within three or four days or may take up to 30 days to develop adequately. Adults - maintenance dosage: Usually 50 - 100mg a day. For maintenance therapy, the total dosage may be given in a single dose preferably in the evening or at bedtime. When satisfactory improvement has been reached, dosage should be reduced to the lowest amount that will maintain relief of symptoms. Ma Lestu allt skjalið